Drug profile · INN
pargyline hydrochloride
EUTONYL
pargyline hydrochloride (EUTONYL) is a monoamine oxidase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — pargyline hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
pargyline hydrochloride (EUTONYL) is a monoamine oxidase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Monoamine oxidase inhibitor
Primary target: Monoamine oxidase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is pargyline hydrochloride?
pargyline hydrochloride (EUTONYL) is a monoamine oxidase inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for pargyline hydrochloride?
EUTONYL is a marketed brand name for pargyline hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pargyline hydrochloride?
pargyline hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.